NCT02537535

Guidelines Oriented Approach to Lipid Lowering (GOAL) in Canada

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 2,027 (actual)
• Sponsor: Canadian Heart Research Centre · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Cross-sectional observational study designed to identify and describe the care gap in guideline-oriented low density lipoprotein cholesterol (LDL-C) management in Canadian patients at high cardiovascular risk.

Detailed description

This is a cross-sectional observational study designed to provide real-life data on the current management of dyslipidemia in high cardiovascular risk patients in routine clinical practice. Canadian guidelines recommend a target for LDL-C of ≤2.0 mmol/L (or ≥50% decrease) after treatment initiation in high-risk patients. The recommended first line treatment is statin therapy. Available data clearly indicates that up to 50% of high risk patients do not achieve this important target because of statin inadequacy or intolerance leading to non-adherence. Therefore this program aims to provide further insights into the challenges Canadian physicians face in helping their high risk patients achieve guideline-recommended LDL-C.

Conditions

• Dyslipidemia

Interventions

Type	Name	Description
OTHER	survey	This is a cross-sectional study without specific intervention

Timeline

• Start date: 2016-01-01
• Primary completion: 2019-12-31
• Completion: 2019-12-31
• First posted: 2015-09-01
• Last updated: 2020-01-23